Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting

Por Konopleva, Marina Y., Jordan, Craig T.
Publicado no J Clin Oncol (2011)

T-PLL: another check on the venetoclax list?

Por Bose, Prithviraj, Konopleva, Marina Y.
Publicado no Blood (2017)

Pathways and mechanisms of venetoclax resistance

Por Bose, Prithviraj, Gandhi, Varsha V., Konopleva, Marina Y.
Publicado no Leuk Lymphoma (2017)

PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice

Por Cheng, Xiaodong, Byrne, Michael, Brown, Kevin D., Konopleva, Marina Y., Kornblau, Steven M., Bennett, Richard L., May, W. Stratford
Publicado no Blood (2015)

Metabolic interrogation as a tool to optimize chemotherapeutic regimens

Por Sandulache, Vlad C., Chen, Yunyun, Feng, Lei, William, William N., Skinner, Heath D., Myers, Jeffrey N., Meyn, Raymond E., Li, Jinzhong, Mijiti, Ainiwaer, Bankson, James A., Fuller, Clifton D., Konopleva, Marina Y., Lai, Stephen Y.
Publicado no Oncotarget (2017)

Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia

Por Ravandi, Farhad, Cortes, Jorge E., Jones, Daniel, Faderl, Stefan, Garcia-Manero, Guillermo, Konopleva, Marina Y., O'Brien, Susan, Estrov, Zeev, Borthakur, Gautam, Thomas, Deborah, Pierce, Sherry R., Brandt, Mark, Byrd, Anna, Bekele, B. Nebiyou, Pratz, Keith, Luthra, Rajyalakshmi, Levis, Mark, Andreeff, Michael, Kantarjian, Hagop M.
Publicado em 2010

Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Por Garcia-Manero, Guillermo, Tambaro, Francesco Paolo, Bekele, Nebiyou B., Yang, Hui, Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Kadia, Tapan M., Konopleva, Marina Y., Faderl, Stefan, Cortes, Jorge E., Brandt, Mark, Hu, Yumin, McCue, Deborah, Newsome, Willie Mae, Pierce, Sherry R., de Lima, Marcos, Kantarjian, Hagop M.
Publicado no J Clin Oncol (2012)

Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myeloid Leukemia

Por Konopleva, Marina Y., Walter, Roland B., Faderl, Stefan H., Jabbour, Elias J., Zeng, Zhihong, Borthakur, Gautam, Huang, Xuelin, Kadia, Tapan M., Ruvolo, Peter P., Feliu, Jennie B., Lu, Hongbo, Debose, LaKiesha, Burger, Jan A., Andreeff, Michael, Liu, Wenbin, Baggerly, Keith A., Kornblau, Steven M., Doyle, L. Austin, Estey, Elihu H., Kantarjian, Hagop M.
Publicado em 2014

Augmented Berlin-Frankfurt-Münster Therapy in Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL)

Por Rytting, Michael E, Thomas, Deborah A, O'Brien, Susan M, Ravandi-Kashani, Farhad, Jabbour, Elias J, Franklin, Anna R, Kadia, Tapan M, Pemmaraju, Naveen, Daver, Naval G., Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Konopleva, Marina Y, Cortes, Jorge E, Borthakur, Gautham, Garris, Rebecca, Cardenas-Turanzas, Maria, Schroeder, Kurt, Jorgensen, Jeffrey L, Kornblau, Steven M, Kantarjian, Hagop M.
Publicado no Cancer (2014)

Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin–Frankfurt–Münster, in adolescents and young adults with acute lymphoblastic le...

Por Rytting, Michael E., Jabbour, Elias J., Jorgensen, Jeffrey L., Ravandi, Farhad, Franklin, Anna R., Kadia, Tapan M., Pemmaraju, Naveen, Daver, Naval G., Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Konopleva, Marina Y., Borthakur, Gautam, Garris, Rebecca, Wang, Sa, Pierce, Sherry, Schroeder, Kurt, Kornblau, Steven M., Thomas, Deborah A., Cortes, Jorge E., O’Brien, Susan M., Kantarjian, Hagop M.
Publicado no Am J Hematol (2016)